cobas pure integrated solutions, Glucose HK Gen.3, ISE indirect Na for Gen.2, ONLINE DAT Methadone II, Elecsys TSH
Hexokinase, Glucose. 510(k) K220134, from Roche Diagnostics (Indianapolis, IN). Product code CFR, class 2.
As of Nov 18, 2026, K220134 is an FDA 510(k) held by Roche Diagnostics, substantially equivalent on Sep 16, 2022 after 241 days, with no recalls tied to it in FDA's recall database.
- Review time: 241 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFcobas pure integrated solutions is an automated analyzer, intended for running qualitative, semi-quantitative and quantitative clinical chemistry and immunochemistry assays as well as ion selective measurements. Glucose HK Gen.3 is an in vitro test for the quantitative determination of glucose in human serum, plasma, urine and CSF on Roche/Hitachi cobas c systems.
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Glucose HK Gen.3, ISE indirect Na for Gen.2, Elecsys TSH, cobas pro integrated solutionsK191899 · Roche Diagnostics · Aug 16, 2019
- Online Dat Ii Methadone IiK021505 · Roche Diagnostics Corp. · Jul 16, 2002
- Cobas 6000 Series SystemK060373 · Roche Diagnostics · Mar 13, 2006
Other CFR clearances
The newest 510(k)s for the same product code; see every CFR device- Glucose HK Gen.3; ONLINE DAT Methadone II; cobas pro integrated solutionsK253490 · Roche Diagnostics · Feb 12, 2026
- Glucose2K252357 · Abbott Ireland · Oct 24, 2025
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 18, 2022
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files